ArticleOncoimmunology2021

An immune-based risk-stratification system for predicting prognosis in pulmonary sarcomatoid carcinoma (PSC).

Haoyue Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.